Impact Biomedical Inc. (IBO)

CIK 1834105 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Impact Biomedical Inc..

Recent SEC filings

FiledFormAccession number
Aug 7, 202610-Q0001493152-26-036601
May 12, 202610-Q0001493152-26-022512
Apr 29, 20261440001493152-26-019682
Apr 22, 2026S-8 POS0001493152-26-018572
Apr 6, 2026S-8 POS0001493152-26-015316
Mar 30, 202640001493152-26-013708
Mar 25, 202640001493152-26-012746
Mar 11, 202610-K0001493152-26-009711
Mar 4, 20268-K0001493152-26-008879
Jan 6, 202640001493152-26-000635
Dec 30, 2025DEF 14C0001493152-25-029621
Dec 11, 2025PRE 14C0001493152-25-027284
Nov 6, 20258-K0001493152-25-021066
Oct 27, 20258-K0001493152-25-019734
Sep 22, 2025DEF 14A0001493152-25-014484
Sep 9, 2025DEF 14C0001641172-25-026976
Aug 25, 2025PRE 14C0001641172-25-025413
Aug 14, 202510-Q0001641172-25-023809
Aug 5, 2025DEF 14C0001641172-25-022267
Jul 28, 20258-K0001641172-25-021085
Jul 16, 2025PRE 14C0001641172-25-019902
Jun 23, 20258-K0001641172-25-016002
May 27, 202540001641172-25-012502
May 14, 202510-Q0001641172-25-010276
Apr 7, 202540001641172-25-003021